Open original FDA record ↗Recall record
- FDA identifier
- Z-3251-2026
- Company in FDA record
- Abiomed, Inc.
- FDA classification date
- Sep 21, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Retrospective report of issues remedied in 2019 with firmware and software patches: 1. Defects in optical bench (OPB) firmware V2.19, which affected the accuracy and stability of the pressure signal the AIC system performance depends on. 2. Software defects leading to unreliable or missing placement signal, unresponsive start Impella soft key during disconnect/reconnect, and false Position in Ventricle alarm in certain AICs.
Source facts
- Action
- No customer notifications were sent. The retrospectively reported recall does not currently affect any Automated Impella Controllers (AICs) in the field pending the correction. The hardware update was implemented to AICs in the field through servicing to address potential safety concerns.
- Initiated
- 2019-02-19
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide and the countries of Austria, Belgium, Canada, France, Germany, Hong Kong, Italy, Luxembourg, Poland, Spain, Switzerland, United Kingdom.
- Recall number
- Z-3251-2026
- Recall status
- Open, Classified
- CDRH record ID
- 222399
- FDA classified
- 2026-09-21
- Recall event number
- 99747